Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Inter-study variability of preclinical in vivo safety studies and translational exposure-QTc relationships--a PKPD meta-analysis.

Gotta V, Cools F, van Ammel K, Gallacher DJ, Visser SA, Sannajust F, Morissette P, Danhof M, van der Graaf PH.

Br J Pharmacol. 2015 Sep;172(17):4364-79. doi: 10.1111/bph.13218. Epub 2015 Jul 21.

2.

Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.

Lafuente-Lafuente C, Valembois L, Bergmann JF, Belmin J.

Cochrane Database Syst Rev. 2015 Mar 28;(3):CD005049. doi: 10.1002/14651858.CD005049.pub4. Review.

PMID:
25820938
3.

Updates in antiarrhythmic therapy for atrial fibrillation in geriatric patients.

Ehrlich C, Tsu LV.

Consult Pharm. 2015 Feb;30(2):82-91. doi: 10.4140/TCP.n.2015.82. Review.

PMID:
25695414
4.

Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.

Lafuente-Lafuente C, Longas-Tejero MA, Bergmann JF, Belmin J.

Cochrane Database Syst Rev. 2012 May 16;(5):CD005049. doi: 10.1002/14651858.CD005049.pub3. Review. Update in: Cochrane Database Syst Rev. 2015;(3):CD005049.

PMID:
22592700
5.

Interventions for the treatment of atrial fibrillation: a systematic literature review and meta-analysis.

Sullivan SD, Orme ME, Morais E, Mitchell SA.

Int J Cardiol. 2013 May 10;165(2):229-36. doi: 10.1016/j.ijcard.2012.03.070. Epub 2012 Apr 1. Review.

PMID:
22469557
6.

Powerful technique to test selectivity of agents acting on cardiac ion channels: the action potential voltage-clamp.

Szentandrássy N, Nagy D, Ruzsnavszky F, Harmati G, Bányász T, Magyar J, Szentmiklósi AJ, Nánási PP.

Curr Med Chem. 2011;18(24):3737-56. Review.

PMID:
21774754
7.

Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses.

Calkins H, Reynolds MR, Spector P, Sondhi M, Xu Y, Martin A, Williams CJ, Sledge I.

Circ Arrhythm Electrophysiol. 2009 Aug;2(4):349-61. doi: 10.1161/CIRCEP.108.824789. Epub 2009 Jun 2. Review.

8.

Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.

Lafuente-Lafuente C, Mouly S, Longas-Tejero MA, Bergmann JF.

Cochrane Database Syst Rev. 2007 Oct 17;(4):CD005049. Review. Update in: Cochrane Database Syst Rev. 2012;5:CD005049.

PMID:
17943835
9.

Adjunctive antiarrhythmic drug therapy in patients with implantable cardioverter defibrillators: a systematic review.

Ferreira-González I, Dos-Subirá L, Guyatt GH.

Eur Heart J. 2007 Feb;28(4):469-77. Epub 2007 Jan 16. Review.

PMID:
17227788
10.

Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation: a systematic review of randomized controlled trials.

Lafuente-Lafuente C, Mouly S, Longás-Tejero MA, Mahé I, Bergmann JF.

Arch Intern Med. 2006 Apr 10;166(7):719-28. Review.

PMID:
16606807
11.

Propagation of population pharmacokinetic information using a Bayesian approach: comparison with meta-analysis.

Dokoumetzidis A, Aarons L.

J Pharmacokinet Pharmacodyn. 2005 Aug;32(3-4):401-18.

PMID:
16320100
12.

Management of atrial fibrillation: review of the evidence for the role of pharmacologic therapy, electrical cardioversion, and echocardiography.

McNamara RL, Tamariz LJ, Segal JB, Bass EB.

Ann Intern Med. 2003 Dec 16;139(12):1018-33. Review.

PMID:
14678922
13.

Transient atrial mechanical dysfunction (stunning) after cardioversion of atrial fibrillation and flutter.

Khan IA.

Am Heart J. 2002 Jul;144(1):11-22. Review. Erratum in: Am Heart J 2002 Aug;144(2):232.

PMID:
12094183
14.

Antiarrhythmic drugs and ventricular defibrillation energy requirements.

Qi X, Dorian P.

Chin Med J (Engl). 1999 Dec;112(12):1147-52. Review.

PMID:
11721458
15.

Pharmacologic conversion of atrial fibrillation: a systematic review of available evidence.

Slavik RS, Tisdale JE, Borzak S.

Prog Cardiovasc Dis. 2001 Sep-Oct;44(2):121-52. Review.

PMID:
11568824
16.

Role of antiarrhythmic therapy in patients at risk for sudden cardiac death: an evidence-based review.

Hilleman DE, Bauman AL.

Pharmacotherapy. 2001 May;21(5):556-75. Review.

PMID:
11349745
17.

Efficacy of agents for pharmacologic conversion of atrial fibrillation and subsequent maintenance of sinus rhythm: a meta-analysis of clinical trials.

Miller MR, McNamara RL, Segal JB, Kim N, Robinson KA, Goodman SN, Powe NR, Bass EB.

J Fam Pract. 2000 Nov;49(11):1033-46.

PMID:
11093570
18.

Dofetilide: a class III-specific antiarrhythmic agent.

Kalus JS, Mauro VF.

Ann Pharmacother. 2000 Jan;34(1):44-56. Review.

PMID:
10669186
19.

Supplemental Content

Loading ...
Support Center